References
- Yezli S, Shibl AM, Livermore DM, Memish ZA. Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia. J Chemother. 2014;26(5):257–272. doi:10.1179/1973947814Y.000000018524669827
- Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002;65(3):455–464.11858629
- Guan X, Xue X, Liu Y, et al. Plasmid-mediated quinolone resistance–current knowledge and future perspectives. J Int Med Res. 2013;41(1):20–30.
- Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438–445. doi:10.1016/j.tim.2014.04.00724842194
- Hooper DC, Jacoby GA. Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci. 2015;1354(1):12–31. doi:10.1111/nyas.1283026190223
- Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 1990;34(6):1271–1272.2168148
- Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother. 1991;35(8):1647–1650.1656869
- Rodriguez-Martinez JM, Machuca J, Cano ME, Calvo J, Martinez-Martinez L, Pascual A. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updat. 2016;29:13–29. doi:10.1016/j.drup.2016.09.00127912841
- Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664–689. doi:10.1128/CMR.00016-0919822894
- Martínez-Martínez L, Cano ME, Rodríguez-Martínez JM, Calvo J, Pascual Á. Plasmid-mediated quinolone resistance. Expert Rev Anti Infect Ther. 2014;6(5):685–711.
- Memish ZA, Shibl AM, Kambal AM, Ohaly YA, Ishaq A, Livermore DM. Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia. J Antimicrob Chemother. 2012;67(7):1701–1705. doi:10.1093/jac/dks09122461312
- Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J. 2010;31(12):1341–1349.21135998
- Babay HA. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005. Jpn J Infect Dis. 2007;60(2–3):123–125.17515646
- Al-Tawfiq JA. Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998–2003. Int j infect dis. 2007;11(2):109–114. doi:10.1016/j.ijid.2005.11.00416750928
- Al-Harthi AA, Al-Fifi SH. Antibiotic resistance pattern and empirical therapy for urinary tract infections in children. Saudi Med J. 2008;29(6):854–858.18521464
- Al-Tawfiq JA, Abed MS. Prevalence and antimicrobial resistance of health care associated bloodstream infections at a general hospital in Saudi Arabia. Saudi Med J. 2009;30(9):1213–1218.19750270
- Akhtar N, Alqurashi AM, Abu Twibah M. In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital. JPMA J Pak Med Assoc. 2010;60(8):625–627.20726190
- Alamri A, Hamid ME, Abid M, et al. Trend analysis of bacterial uropathogens and their susceptibility pattern: a 4-year (2013–2016) study from Aseer region, Saudi Arabia. Urology Annals 2018;10(1):41.
- Cockerill FR. Performance standards for antimicrobial susceptibility testing: Twenty-first informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2011.
- Wise R, Andrews JM. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone. J Antimicrob Chemother. 1999;44(5):679–688.10552986
- Grillon A, Schramm F, Kleinberg M, Jehl FJPO. Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia assessed by minimum inhibitory concentrations and time-kill studies. PLoS One. 2016;11(6):e0156690. doi:10.1371/journal.pone.015669027257956
- El-Badawy MF, Tawakol WM, El-Far SW, et al. molecular identification of aminoglycoside-modifying enzymes and plasmid-mediated quinolone resistance genes among Klebsiella pneumoniae clinical isolates recovered from Egyptian Patients. Int J Microbiol. 2017;2017:8050432. doi:10.1155/2017/805043228638412
- El-Badawy MF, Tawakol WM, Maghrabi IA, Mansy MS, Shohayeb MM, Ashour MS. Iodometric and molecular detection of ESBL production among clinical isolates of E. coli fingerprinted by ERIC-PCR: the first Egyptian report declares the emergence of E. coli O25b-ST131clone Harboring blaGES. Microb Drug Resist. 2017;23(6):703–717. doi:10.1089/mdr.2016.018128099061
- Asghar AH, Faidah HS. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia. Saudi Med J. 2009;30(8):1017–1023.
- Cayci YT, Coban AY, Gunaydin M. Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa clinical isolates. Indian J Med Microbiol. 2014;32(3):285–289. doi:10.4103/0255-0857.13656725008822
- Saleh MA, Balboula MM. Plasmid mediated quinolone resistance determinants among nosocomial clinical Pseudomonas aeruginosa isolates. Int Curr Microbiol App Sci2017;6(1):42–50.
- Yang X, Xing B, Liang C, Ye Z, Zhang Y. Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med. 2015;8(1):1386–1390.25785142
- Araujo BF, Ferreira ML, de Campos PA, et al. Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac (6’)-Ib-cr, qnrS1 and blaSPM Genes in Brazil. 2016;11(5):e0155914.
- Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. BJM 2014;45(4):1455–1458.
- Al-Marjani MF. Presence of qnr gene in environmental and clinical Pseudomonas aeruginosa isolates in Baghdad. Int J Curr Microbiol Appl Sci 2014;3(7):853–857.
- Baron S. Epidemiology–Medical Microbiology. Galveston, TX: University of Texas Medical Branch at Galveston; 1996.
- Meacham KJ, Zhang L, Foxman B, Bauer RJ, Marrs CF. Evaluation of genotyping large numbers of Escherichia coli isolates by enterobacterial repetitive intergenic consensus-PCR. J Clin Microbiol. 2003;41(11):5224–5226.14605168
- Wilson LA, Sharp PM. Enterobacterial repetitive intergenic consensus (ERIC) sequences in Escherichia coli: evolution and implications for ERIC-PCR. Mol Biol Evol. 2006;23(6):1156–1168. doi:10.1093/molbev/msj12516533821
- Tripathi MK, Kumar M, Singh VK, Nath G, Asthana RK. Use of enterobacterial repetitive intergenic consensus PCR in detecting target (s) of Hapalindole-T, From a Cyanobacterium, in Escherichia Coli: in Silico Validation. Am J Bioinf. 2012;1(1):30–40.
- Hulton CS, Higgins CF, Sharp PM. ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enterobacteria. Mol Microbiol. 1991;5(4):825–834.1713281
- Asgarani E, Ghashghaei T, Soudi MR, Alimadadi N. Enterobacterial repetitive intergenic consensus (ERIC) PCR based genetic diversity of Xanthomonas spp. and its relation to xanthan production. Iran J Microbiol. 2015;7(1):38–44.26644872
- Waturangi DE, Joanito I, Yogi Y, Thomas S. Use of REP- and ERIC-PCR to reveal genetic heterogeneity of Vibrio cholerae from edible ice in Jakarta, Indonesia. Gut Pathog. 2012;4(1):2. doi:10.1186/1757-4749-4-224576322
- Ishii S, Sadowsky MJ. Applications of the rep-PCR DNA fingerprinting technique to study microbial diversity, ecology and evolution. Environ Microbiol. 2009;11(4):733–740. doi:10.1111/j.1462-2920.2008.01856.x19207574
- Sun F, Yang S, Chen X. Detection of intestinal pathogenic klebsiella pneumoniae from fecal samples of giant panda by polymerase chain reaction. J Biotech Res. 2013;5:10.
- Da Silva Filho LVF, Levi JE, Bento CN, Ramos SR, Rozov T. PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients. J Med Microbiol. 1999;48(4):357–361. doi:10.1099/00222615-48-4-35710509477
- Cattoir V, Poirel L, Rotimi V, Soussy C-J, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J antimicrob chemother. 2007;60(2):394–397. doi:10.1093/jac/dkm20417561500
- Pribul BR, Festivo ML, Souza MM, Rodrigues DD. Characterization of quinolone resistance in Salmonella spp. isolates from food products and human samples in Brazil. braz J microbiol. 2016;47(1):196–201. doi:10.1016/j.bjm.2015.04.00126887245
- Chen X, Zhang W, Pan W, et al. Prevalence of qnr, aac (6′)-Ib-cr, qepA, and oqxAB in Escherichia coli Isolates from Humans, Animals, and Environment. Antimicrob Agents Chemother. 2012;56(6):3423–3427.
- Hammad E, Helal R. PMQR determinants among clinical isolates of ESBL and Amp C producing serratia marcescens in Mansoura University Hospitals: a six year study. Int Arabic J Antimicrob Agents. 2015;5:3.